ATG5 and colorectal carcinoma: Recent research reported intestinal adenoma and augments interferon-gamma’s therapeutic effects were increased when systemic heterozygous removal of ATG5 occurs in ApcMin/+ mice, revealing that autophagy inhibition through interfering with ATG5 function could be an efficient strategy for preventing and treating CRC [97].